Emerging Trends In Transdermal Therapy: The Role Of Ethosomes, Transfersomes, And Menthosomes

Abstract

Transdermal Drug Delivery Systems Offer A Non-invasive And Patient-friendly Method For Administering Medications, Particularly For Chronic Conditions Requiring Sustained Release. Among The Various Nanocarrier-based Systems, Ethosomes, Transfersomes, And Menthosomes Have Emerged As Advanced Vesicular Carriers Due To Their Capability To Improve Drug Permeation Through Skin. Ethosomes, Developed By Touitou, Are Ethanol-based Flexible Vesicles Composed Of High Concentrations Of Alcohol, Phospholipids, And Water, Facilitating Deep Skin Penetration And Systemic Delivery. Transfersomes, Comprising Phospholipids And Edge Activators, Are Ultra-deformable Vesicles Known For Their Capability To Traverse Stratum Corneum Efficiently. Menthosomes, A Newer Class, Incorporate Menthol, Phospholipids, And Surfactants To Improve Skin Permeability And Drug Diffusion. These Carriers Are Especially Suitable For Delivering Large Molecules Like Peptides And Proteins, Offering Improved Patient Compliance And Effectiveness In Treating A Variety Of Dermatological And Systemic Conditions. However, Challenges Such As Chemical Instability, Limited Skin Adhesion, And Potential Skin Irritation Remain. Despite These Limitations, Their Enhanced Skin Permeation, Potential For Gene And Anticancer Drug Delivery, And Sustained Release Capabilities Position Them As Promising Tools In Transdermal Therapy. Further Studies Are Needed To Fully Explore The Comparative Efficacy Of These Novel Vesicular Systems.

Keywords